Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
--------
Question: The local money will be added to $56 million already appropriated for the new clinic, which will be part of the VA's Nebraska/Western Iowa Health Care System. The $86 million facility will be built on the campus of the current VA hospital in Omaha. "This project will lay the groundwork for future public-private partnerships aimed at providing veterans access to state-of-the-art facilities and will significantly improve the quality of care we are able to provide to our nation's veterans," said Veterans Affairs Secretary David Shulkin in a news release. President Barack Obama in December signed a measure, dubbed the Chip In for Vets Act, that allows the public-private partnership. It was sponsored by U.S. Rep Brad Ashford, who represented Nebraska's 2nd Congressional District until losing his bid for re-election in November. VA officials have said the clinic that will be called the Veterans Affairs Ambulatory Center will offer primary, specialty and ambulatory care and operate radiological and surgical facilities. The current hospital will remain standing, and once the ambulatory care center is built, the hospital will be used primarily for administrative operations with some medical services, said Nebraska/Western Iowa Health Care System spokesman William Ackerman. He couldn't immediately say where the four other pilot projects will occur. VA officials in Washington didn't immediately return messages. Design work on the Omaha project will continue through 2017, and officials anticipate site work and construction will begin in early 2018, said Sue Morris, president of Heritage Services, a nonprofit civic group involved in the project. A 2007 study found the current Omaha hospital was plagued by problems in its electrical, heating and cooling systems. In 2011, the VA unveiled plans for a $560 million replacement. Congress approved $56 million to start the project planning, and the new structure tentatively was scheduled to open in 2018. But the plans and work were delayed by funding shortages and changing VA priorities. The public-private project had been projected to cost $136 million $56 million from federal sources, $80 million from local benefactors. But Ackerman said the figure was decreased after details were refined since the number was discussed after Obama signed the legislation. The local corporation, the Veterans Ambulatory Center Development Corp., which will oversee design, construction and fundraising, was created by Heritage Services. Heritage Services was instrumental in creating major Omaha projects such as the Holland Performing Arts Center and TD Ameritrade Park, where the College World Series is held. ___ Information from: Omaha World-Herald, http://www.omaha.com

Answer: Nonprofit group commits $30M for new Omaha VA facility.

Question: No one was killed in the incident in Mato Grosso state, ANM said in a statement. The dam is registered under the name of an individual wildcat miner rather than in the name of a mining company. Inspections of the dam had not turned up any problems, and it had been declared as stable on Sept. 25, the agency said. Brazil remains on high alert for dam ruptures after a tailings dam at a Vale SA iron ore mine burst in January, killing at least 250 people in the second major disaster of its kind in four years.

Answer: Health tourism costs nearly 300 million on some estimates.

Question: As this is not an available treatment, the cost was presented as something not yet known. The story suggested that the cost for the pill would likely be something less than $17/month the cost for its component medications. The story did not provide a rational for why the expected costs would be less than the costs for the individual medications on their own. Nonetheless, it tried to address cost. The benefits of treatment in terms of blood pressure, LDL cholesterol, triglycerides, HDL, and anti-clotting were presented However, it is premature to present an estimate for the reduction in heart attack and stroke as the time frame of the study presented is much too short to inform us as to whether this is the case. There was no discussion of harms of treatment beyond a statement that the side effect rates for the polypill were the same as for the medications individually. While this was what was observed in the current 12 week trial, the reader should have been reminded of the short term nature of the study, the limited demographics of the study population, and that conclusions, although informed by the common long-term use of the component medications, still require analysis of the effects these medications may have in individuals who may not have all of the underlying conditions being treated. Although the story did an adequate job of describing the results of the study, it did not confine itself to discussion of the observed outcomes but chose to focus on extrapolating the results to what might be the longer term benefit. Stating that this pill could 'cut a person's risk of heart disease and stroke roughly in half, the study concludes' implies that the pill was tested for its effect on cardiovascular outcomes, when in fact it has only been shown to reduce risk factors levels in a single, short-term study. This is misleading. The story did not engage in overt disease mongering. Quotes from a number of clinicians involved in the current study, and individuals who were supportive or critical of the current treatment approach were included in this story. While the story failed to mention options other than the use of multiple pharmaceuticals to lower risk of heart attack and stroke, it did touch on the use of the drugs separately rather than in combined form. The story made clear that the combination pill discussed was experimental, while at the same time indicating that all of its components were available as generic medications. The novelty of such a polypill was appropriately portrayed. Does not appear to rely on a press release.

Answer:
Once-a-day heart combo pill shows promise in study